Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing
NCT02861651
·
clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
OTHER:
DNA sequencing
Sponsor
Institut Paoli-Calmettes